The goal of this clinical trial is to know if telemonitoring and telematic follow-up reduces the healthcare resources utilization, healthcare costs and non-healthcare costs of patients with high-risk heart failure. The main questions it aims to answer are: * Does telematic follow-up reduce de use of healthcare resource utilization of patients with heart failure? * Is telematic follow-up cost-efficient in terms of reducing direct healthcare costs in heart failure patients? * Is telematic follow-up cost-efficient in terms of reducing non-healthcare costs in heart failure patients? Participants will be randomized to usual care (control group) or telematic care (interventional group). Patients randomized to the interventional group will be included in a protocol of daily automatic telemonitoring of arterial pressure, peripheral oximetry, heart rate and weight, and telematic consultations lead by a heart failure clinical specialized team. Researchers will compare the healthcare resource utilization, healthcare and non-healthcare costs of patients randomized to control vs. interventional group.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Enrollment
390
Home telemonitoring of blood pressure, heart rate and peripheral oxygen saturation on a daily basis during 12 months
Hospital Universitario 12 de Octubre
Madrid, Madrid, Spain
RECRUITINGHealth care costs
Sum of the costs for the consumption of medicines, primary care consultations, specialist consultations, hospitalization, emergency care and medical transport.
Time frame: 12 months
Non-health care costs
Sum of informal costs (care provided by people who are not health or social care professionals) and professional costs (home help, tele-health, tele-assistance, ambulatory care centers and use of nursing homes)
Time frame: 12 months
Symptoms
Measured using New York Heart Association dyspnea scale
Time frame: 12 months
Care burden of caregivers
Measured using Zarit scale (values 0 to 88)
Time frame: 12 months
Number of hospital admissions
For any cause, cardiovascular and for heart failure.
Time frame: 12 months
Mortality
For any cause and for cardiovascular cause
Time frame: 12 months
Patient satisfaction with service
Measured using a customer satistaction questionnaire (values 0 to 20), with higer scores meaning
Time frame: 12 months
Adherence to the telemonitoring protocolo
Number of transmissions made versus planned at 12 months.
Time frame: 12 months
Quality of life variation
Euroqol-5D-5L questionnaire
Time frame: 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.